SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019691
Filing Date
2023-12-08
Accepted
2023-12-08 16:05:35
Documents
13
Period of Report
2023-12-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20231207x8k.htm   iXBRL 8-K 37913
2 EX-3.1 bpth-20231207xex3d1.htm EX-3.1 7781
  Complete submission text file 0001558370-23-019691.txt   171335

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpth-20231207.xsd EX-101.SCH 3154
4 EX-101.LAB bpth-20231207_lab.xml EX-101.LAB 16580
5 EX-101.PRE bpth-20231207_pre.xml EX-101.PRE 10522
7 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20231207x8k_htm.xml XML 5055
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 231475402
SIC: 2834 Pharmaceutical Preparations